Acute Hypokalaemia Protocol
How fast the potassium can go, by which route, and what must be corrected with it · v1.1- Enter the potassium, the ECG findings, the magnesium, the symptoms, and whether the patient tolerates oral intake and has intravenous access.
- You get a stepwise replacement protocol with the route, the rate, the ceiling, magnesium co-correction and a monitoring plan.
- It will not correct a potassium the magnesium is holding down, so enter the magnesium wherever it has been measured.
- Count any potassium already running. The plan it prints sits on top of an existing infusion, not instead of it.
- Children and adolescents under 18.
- The cause of the low potassium. The differential on the Evidence tab is a prompt, not a pathway.
- The renal tubular disorders, the periodic paralyses and the aldosterone excess that sit behind a persistently low potassium in a patient on no diuretic.
- Diabetic ketoacidosis, apart from the potassium rule inside it.
- Potassium already running in a fluid, which it cannot see.
1. The Magnesium Gate: Why Potassium Will Not Rise Without Magnesium
About 40 to 60 per cent of hypokalaemic patients are concurrently hypomagnesaemic, and the hypokalaemia is refractory to potassium replacement until the magnesium is corrected. Magnesium depletion activates ROMK (Renal Outer Medullary Potassium) channels in the distal nephron, so the kidney goes on wasting potassium however much KCl is given. Check and correct magnesium first.
If several doses of KCl have gone in and the potassium is not rising, the most likely cause is uncorrected hypomagnesaemia. Check serum magnesium immediately. Do not keep escalating KCl doses before fixing the magnesium.
2. The Digoxin Interaction
Digoxin and potassium compete for the same binding site on the Na+/K+-ATPase pump, so as the potassium falls more digoxin binds, at any digoxin level. A normal level does not exclude toxicity.
- Look for nausea, visual disturbance with yellow-green halos, and the life-threatening arrhythmias: bidirectional VT, accelerated junctional rhythm, atrial tachycardia with block.
- In a patient on digoxin, hypokalaemia is a medical emergency and is corrected urgently.
3. Intravenous KCl: Rate, Concentration and Safety Limits
Intravenous potassium chloride is a high-alert medication. Errors in rate or concentration cause fatal hyperkalaemia and cardiac arrest. The limits below are absolute.
| Parameter | Peripheral IV | Central Line | Cardiac Arrest |
|---|---|---|---|
| Maximum Rate | 10 mEq/hour | 20 mEq/hour | 40 mEq/hour (ICU only) |
| Maximum Concentration | 40 mEq/L | 60 to 80 mEq/L | As per protocol |
| Preferred Diluent | Normal Saline (0.9% NaCl). Never use dextrose-containing fluids - insulin release from dextrose drives K+ intracellularly and worsens hypokalaemia. | ||
| Monitoring | Repeat K+ every 4 h | Continuous telemetry + K+ every 2 h | Continuous telemetry + K+ every 1 h |
This causes instantaneous local hyperkalaemia in the cardiac conduction system, leading to VF and death within seconds. KCl must always be diluted and infused at a controlled rate.
KCl concentrations above 40 mEq/L through peripheral veins cause severe phlebitis and pain. If the patient reports burning at the IV site, slow the rate or dilute further. Adding 1 to 2 mL of 2% Lidocaine to the infusion bag can reduce pain but is not universally practised.
4. Oral Potassium Replacement
Oral replacement is safer, more physiological and preferred whenever the patient can tolerate it: absorption is efficient and the risk of overshoot is lower than with the intravenous route. Preparations in India:
| Preparation | Brands | K+ Content | Notes |
|---|---|---|---|
| KCl syrup (elixir) | Potklor | 20 mEq per 15 mL | Bitter taste. Mix with juice. Commonest form in Indian hospitals. |
| KCl slow-release tablets | Check local stock | 8 mEq (600 mg) per tablet | Better tolerated. Do not crush, which defeats the slow-release coat. We could not verify which slow-release brands are stocked in India, so none is named here. |
| Potassium Citrate | Check local stock | Variable | Preferred in RTA and metabolic acidosis, because it provides alkali. Not ideal for routine replacement. We could not verify which potassium citrate brands are stocked in India, so none is named here. |
- Gastrointestinal side effects (nausea, vomiting, abdominal cramps, diarrhoea) are the main limitation and are dose-related. Dividing the dose across the day, 20 mEq three times daily with meals, reduces intolerance significantly.
5. ECG Progression of Hypokalaemia
The changes are progressive but may not track the serum potassium closely. Some patients develop arrhythmias at relatively mild levels, especially on digoxin or with concurrent hypomagnesaemia.
| Stage | ECG Finding | Typical K+ Range | Clinical Significance |
|---|---|---|---|
| Early | ST segment depression, T wave flattening | 3.0 - 3.5 mEq/L | Subtle and easily missed. Compare with prior ECGs. |
| Moderate | Prominent U waves (best seen in V2-V3), apparent QT prolongation (actually QU prolongation) | 2.5 - 3.0 mEq/L | U wave is the hallmark ECG finding of hypokalaemia. May be confused with a long QT. |
| Severe | T-U wave fusion, ST depression deepens, PR prolongation | 2.0 - 2.5 mEq/L | Increased risk of atrial and ventricular ectopy. |
| Life-threatening | VT, VF, Torsades de Pointes, asystole | < 2.0 mEq/L | Cardiac arrest. Often triggered by concurrent hypomagnesaemia or digoxin. |
6. Total Body Potassium Deficit Estimation
Serum potassium is only 2 per cent of total body potassium, so serum levels significantly underestimate total body depletion. The approximation below is widely used and is a rough guide only.
| Serum K+ (mEq/L) | Approximate Total Body Deficit | Clinical Implication |
|---|---|---|
| 3.0 - 3.4 | 100 - 200 mEq | Usually correctable with oral replacement over 24 to 48 hours. |
| 2.5 - 2.9 | 200 - 400 mEq | May require combined oral and IV therapy. Takes 2 to 3 days to fully correct. |
| 2.0 - 2.4 | 400 - 600 mEq | Significant deficit. IV therapy required. Full correction takes 3 to 5 days. |
| < 2.0 | > 600 mEq | Very large deficit. IV replacement with continuous monitoring. Full correction may take a week. |
7. Differential Diagnosis of Hypokalaemia
| Transcellular Shift | Renal Losses | GI Losses | Inadequate Intake |
|---|---|---|---|
| Insulin therapy / DKA treatment | Loop diuretics (Furosemide) | Diarrhoea (most common GI cause) | Alcoholism / malnutrition |
| Beta-2 agonists (Salbutamol) | Thiazide diuretics (HCTZ) | Vomiting / NG suction (causes renal loss via metabolic alkalosis) | Anorexia nervosa |
| Metabolic alkalosis | Hyperaldosteronism (Conn syndrome) | Laxative abuse | Tea-and-toast diet (elderly) |
| Thyrotoxic periodic paralysis | Cushing syndrome / exogenous steroids | Villous adenoma of colon | Prolonged NPO without K supplementation |
| Hypothermia / refeeding syndrome | RTA Type 1 and Type 2 | Fistulae / ostomy output | |
| Bartter / Gitelman syndrome | |||
| Amphotericin B / Cisplatin nephrotoxicity |
8. DKA and Hypokalaemia: The Insulin Effect
In diabetic ketoacidosis the total body potassium is always depleted, typically by 200 to 600 mEq, even when the presenting serum K+ is normal or high: acidosis and insulin deficiency shift potassium out of cells and mask the deficit. Start insulin and it moves back in, and the serum K+ can fall within minutes.
Do not start insulin if serum K+ is below 3.5 mmol/L. Replace potassium first, 10 to 20 mmol/h IV KCl, until K+ is above 3.5, then start insulin. Above 10 mmol/h a central line and telemetry are required. If K+ is 3.5 to 5.3 mmol/L, add 20 to 30 mmol KCl to each litre of IV fluid. If K+ is above 5.3 mmol/L, hold KCl and recheck every 2 hours. Insulin unmasks the deficit.
Followed here: Diabetes Care 2024;47:1257. Superseded: Kitabchi 2009 held insulin below 3.3 mmol/L and gave 20 to 40 mEq/h.
References
- Unwin RJ, Luft FC, Shirley DG. Pathophysiology and management of hypokalemia: a clinical perspective. Nat Rev Nephrol. 2011;7(2):75-84.
- Crop MJ, Hoorn EJ, Lindemans J, Zietse R. Hypokalaemia and subsequent hyperkalaemia in hospitalized patients. Nephrol Dial Transplant. 2007;22(12):3471-3477.
- Huang CL, Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol. 2007;18(10):2649-2652.
- Kardalas E, Paschou SA, Anagnostis P, et al. Hypokalemia: a clinical update. Endocr Connect. 2018;7(4):R135-R146.
- Umpierrez GE, Davis GM, ElSayed NA, et al. Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care. 2024;47(8):1257-1275.
- Indian Council of Medical Research (ICMR). Standard Treatment Workflows - Electrolyte Emergencies. 2019.
- Viera AJ, Wouk N. Potassium Disorders: Hypokalemia and Hyperkalemia. Am Fam Physician. 2015;92(6):487-495.
- Palmer BF, Clegg DJ. Physiology and Pathophysiology of Potassium Homeostasis: Core Curriculum 2019. Am J Kidney Dis. 2019;74(5):682-695.
How to Cite This Tool
DOIhttps://doi.org/10.5281/zenodo.22401532
AMA Style:Umakanth S. Acute Hypokalaemia Protocol. Version 1.1. MEDiscuss Clinical Decision Support System. Published 2026. Accessed . https://mediscuss.org/cdss/acute-hypokalaemia. doi:10.5281/zenodo.22401532
Vancouver Style:Umakanth S. Acute Hypokalaemia Protocol [Internet]. Version 1.1. MEDiscuss.org; 2026 [cited ]. Available from: https://mediscuss.org/cdss/acute-hypokalaemia. doi:10.5281/zenodo.22401532
Save this calculation
Whatever you type here stays on this device and is not sent anywhere. The server receives only a scrambled code made from it, so nobody with access to the server can tell which patient a saved calculation belongs to. Enter the same nickname the next time to see that patient's earlier values. What is stored